Clinical Trials Browser

Completed × WW Domain-Containing Oxidoreductase × Clear all

NCT03723291 2026-03-03

PITSTOP

Phase 1 Completed

Head and Neck Fibrosis

NCT02303821 2025-06-04

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 1 Completed

141 enrolled 37 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04049747 2025-03-24

IP4-CHRONOS

Phase NA Completed

100 enrolled 23 charts

Prostatic Neoplasms

NCT02412878 2022-09-23

ARROW

Phase 3 Completed

478 enrolled 17 charts

Multiple Myeloma

NCT02335983 2020-11-06

Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma

Phase 1 Completed

107 enrolled 25 charts

NCT00481871 2020-01-07

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Phase 1/2 Completed

119 enrolled 13 charts

LymphoidOther hematologic neoplasm

Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT01335893 2018-02-05

Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green

Phase 1 Completed

Lung Neoplasms

NCT00511238 2017-08-31

Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma

Phase 2 Completed

312 enrolled 16 charts

Multiple Myeloma, Recurrence

NCT01980589 2017-05-30

CHAMPION 2

Phase 1 Completed

22 enrolled 11 charts

Multiple Myeloma

NCT00530816 2017-05-02

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Phase 2 Completed

164 enrolled 16 charts

Multiple Myeloma

NCT01949545 2017-05-02

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Phase 1 Completed

46 enrolled 45 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT00441870 2012-03-09

Study of EC0225 for the Treatment of Refractory or Metastatic Tumors

Phase 1 Completed

Neoplasm Metastasis, Neoplasms

NCT00051974 2008-02-11

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00051987 2008-02-11

Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00063713 2008-02-11

VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Completed

Lymphoma, Mantle-Cell

NCT00064610 2008-02-11

Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms